Teens Are Taking More Reliable Birth Control
The teen birth rate in the U.S. has been declining consistently for more than 30 years, despite the fact that the number of teenage girls having sex has not changed since at least 2002. A new report from the U.S. Centers for Disease Control and Prevention (CDC) suggests a key driver of this trend: a dramatic increase in teenage girls using long-lasting and reliable forms of contraception. The percentage of girls ages 15 to 19 using long-acting reversible contraception, which includes intrauterine devices (IUDs) and contraceptive implants, reached a reported high of 19% from 2015-2019. That’s more than three times...
Source: TIME: Health - December 14, 2023 Category: Consumer Health News Authors: Haley Weiss Tags: Uncategorized healthscienceclimate Source Type: news

Is Your Birth Control as Safe as You Think?
Since NuvaRing hit the market, more than 700 women have filed lawsuits, claiming it has caused potentially life-threatening blood clots. The battle may change the way millions of women prevent pregnancy. (Source: WebMD Health)
Source: WebMD Health - March 14, 2023 Category: Consumer Health News Source Type: news

EluRyng (Etonogestrel and Ethinyl Estradiol Vaginal Ring) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 14, 2020 Category: Drugs & Pharmacology Source Type: news

EluRyng (Etonogestrel and Ethinyl Estradiol Vaginal Ring) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 3, 2020 Category: Drugs & Pharmacology Source Type: news

Prasco launches NuvaRing(R) (etonogestrel/ethinyl estradiol vaginal ring) Authorized Generic in the United States
MASON, Ohio, Dec. 17, 2019 -- (Healthcare Sales & Marketing Network) -- Prasco announced today the launch of the authorized generic of NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring). This is Prasco's 9th authorized generic launch in partnersh... Biopharmaceuticals, Generics, Drug Delivery, Product Launch Prasco Laboratories, NuvaRing, etonogestrel, estradiol, vaginal ring (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 17, 2019 Category: Pharmaceuticals Source Type: news

FDA Approves EluRyng (etonogestrel/ethinyl estradiol vaginal ring), the First Generic NuvaRing
BRIDGEWATER, N.J.--(BUSINESS WIRE) December 12, 2019 -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the“Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S.... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 12, 2019 Category: Drugs & Pharmacology Source Type: news

NuvaRing (vaginal ring)
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - January 12, 2018 Category: Consumer Health News Source Type: news

Glenmark, Evestra ink deal to develop generic NuvaRing
Glenmark Pharmaceuticals and Evestra said today that the companies inked a development, license and commercialization deal for a generic version of Merck’s NuvaRing. Development of the etonogestrel/ethinyl estradiol contraceptive is under way, according to the companies, and they plan to file an Abbreviated New Drug Application in fiscal 2019. Get the full story at our sister site, Drug Delivery Business News. The post Glenmark, Evestra ink deal to develop generic NuvaRing appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - March 2, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Research & Development Wall Street Beat Women's Health Evestra Glenmark Pharmaceuticals Source Type: news

Local biopharmaceutical company strikes deal with global player
San Antonio-based Evestra Inc. has struck a deal with a global pharmaceutical company that could open a world of new business opportunities. It ’s entered into a strategic development, licensing and commercialization agreement with Glenmark Pharmaceuticals to develop and market a generic version of Merck& Co. Inc. ’s NuvaRing birth control product. Evestra — an emerging player in biopharmaceutical research and development with a therapeutic focus on women’s health care — plans to develop… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 1, 2017 Category: Biotechnology Authors: W. Scott Bailey Source Type: news

Local biopharmaceutical company strikes deal with global player
San Antonio-based Evestra Inc. has struck a deal with a global pharmaceutical company that could open a world of new business opportunities. It ’s entered into a strategic development, licensing and commercialization agreement with Glenmark Pharmaceuticals to develop and market a generic version of Merck& Co. Inc. ’s NuvaRing birth control product. Evestra — an emerging player in biopharmaceutical research and development with a therapeutic focus on women’s health care — plans to develop… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 1, 2017 Category: American Health Authors: W. Scott Bailey Source Type: news

Meet 10 Women Who Rushed To Get An IUD Before Inauguration Day
Since the morning of November 9, when it was clear that Donald Trump would become the 45th president, droves of women have gone to their gynecologists seeking low-cost, long-acting reversible contraception before Trump’s inauguration ― and before the GOP dismantles the Affordable Care Act.  Planned Parenthood reports that the demand for IUDs has gone up 900 percent since the election. And women’s health care providers say they have heard from women who are frightened about what the next four years will bring for their reproductive rights.  Some got their IUDs and implants months ago, and others...
Source: Healthy Living - The Huffington Post - January 18, 2017 Category: Consumer Health News Source Type: news

19 Women On Why Birth Control Is So Damn Important
Birth control is an essential aspect of many women’s health care ― and with the threat of losing affordable access to it under the Trump and Pence administration, women are extra eager to celebrate it.   Whether it’s an IUD, the pill, the implant or the NuvaRing, women all over the country know that their birth control routines are much more than “nitty gritty” details of their lives. (Sorry, Paul Ryan!) In honor of the full lives that access to contraception allows women to live, non-profit online birth control support network Bedsider started the hashtag #ThxBirthControl on W...
Source: Healthy Living - The Huffington Post - November 16, 2016 Category: Consumer Health News Source Type: news

NuvaRing (Etonogestrel, Ethinyl Estradiol Vaginal Ring) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 17, 2016 Category: Drugs & Pharmacology Source Type: news

Is Your Birth Control as Safe as You Think?
Since NuvaRing hit the market, more than 700 women have filed lawsuits, claiming it has caused potentially life-threatening blood clots. The battle may change the way millions of women prevent pregnancy. (Source: WebMD Health)
Source: WebMD Health - December 21, 2015 Category: Consumer Health News Source Type: news

Sweetening the pill: could some birth-control methods kill you?
A documentary film is seeking funds on Kickstarter to investigate the side-effects of female contraceptives such as NuvaRing and Laryna. The Guardian (Source: Society for Endocrinology)
Source: Society for Endocrinology - June 22, 2015 Category: Endocrinology Source Type: news